Rubicon Organics Reports 2025 Financial Results

Core Insights - Rubicon Organics Inc. reported record revenues and operational milestones for the year ended December 31, 2025, positioning itself strongly for growth in 2026 [2][3][4] Financial Performance - The company achieved record net revenue of CAD 59.5 million for 2025, a 22% increase from 2024, with Q4 2025 net revenue reaching CAD 16.5 million, up 16% from Q4 2024 [3][4] - Adjusted EBITDA for the year was CAD 5.0 million, reflecting a 25% increase from 2024, and the company generated income from operations of CAD 1.8 million, a turnaround from a loss of CAD 1.2 million in 2024 [3][4] - Gross profit before fair value adjustments was CAD 19.5 million, a 27% increase from 2024, with a gross profit of CAD 22.1 million after adjustments [4][5] Operational Highlights - The Cascadia Facility was rapidly integrated, with its first harvests completed in February 2026, and is expected to significantly enhance production capacity [2][6][8] - The company has a combined annual production capacity of 15,500 kg across its two facilities, which positions it well to meet growing domestic and international demand [7][17] Market Position - Rubicon Organics is recognized as the 1 premium licensed producer in Canada, driven by its leading brand, 1964 Supply Co.™, and holds an 18% national market share of premium vapes [4][8] - The company has also achieved significant market share with its Wildflower™ brand, which is the 2 topical brand in Canada with a 25.9% market share [4] Strategic Initiatives - The company is focused on improving gross margins through increased production efficiency and reduced reliance on third-party suppliers [12] - Rubicon is launching new genetic strains in 2026 to maintain its leadership in the premium cannabis segment and drive consumer loyalty [10] International Expansion - Following successful international shipments in 2025, Rubicon is set to launch its 1964 Supply Co.™ brand in key international markets in 2026 [11] Future Outlook - The company anticipates growth in both net revenue and Adjusted EBITDA for 2026, driven by increased capacity and strategic initiatives, despite facing near-term pressures in the first half of the year [14]